• #927964
  • 109
  • Merck #00006409502

Vaqta® Hepatitis A Vaccine Pediatric / Adolescent, 12 Months Through 18 Years of Age 25 Unit / 0.5 mL Injection Prefilled Syringe 0.5 mL

VAQTA 25U SYR 10X0.5ML

Features
  • VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older
  • VAQTA is a sterile suspension for intramuscular injection
  • One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen, which is purified and formulated without a preservative
  • More …
Container Type
Prefilled Syringe Single Dose Vial
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #927964
Manufacturer #00006409502
BrandVaqta®
ManufacturerMerck
Country of OriginUnited States
ApplicationHepatitis A Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
Generic Drug Code32393
Generic Drug NameHepatitis A Virus Vaccine / Preservative Free
NDC Number00006-4095-02
Product DatingMcKesson Acceptable Dating: we will ship >= 180 days
Storage RequirementsRequires Refrigeration
Strength25 Unit / 0.5 mL
TypeIntramuscular
UNSPSC Code51201626
UserPediatric / Adolescent, 12 Months Through 18 Years of Age
Volume0.5 mL
Features
  • VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older
  • VAQTA is a sterile suspension for intramuscular injection
  • One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen, which is purified and formulated without a preservative
  • Each 0.5-mL pediatric dose contains 25U of hepatitis A virus antigen and adsorbed onto approximately 0.225 mg of aluminum provided as amorphous aluminum hydroxy phosphate sulfate, and 35 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride